Bear Mountain Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33K Buy
130
+1
+0.8% +$233 0.01% 70
2026
Q1
$29.9K Sell
129
-31
-19% -$7.22K 0.01% 77
2025
Q4
$35.1K Sell
160
-1
-0.6% -$198 0.01% 73
2025
Q3
$30.9K Buy
161
+3
+2% +$514 0.01% 78
2025
Q2
$25.9K Buy
158
+1
+0.6% +$154 0.01% 79
2025
Q1
$24.5K Buy
157
+126
+406% +$19.7K 0.01% 81
2024
Q4
$4.55K Hold
31
﹤0.01% 112
2024
Q3
$5.09K Hold
31
﹤0.01% 108
2024
Q2
$4.65K Sell
31
-66
-68% -$9.82K ﹤0.01% 114
2024
Q1
$14K Sell
97
-8
-8% -$1.27K 0.01% 96
2023
Q4
$16.9K Buy
+105
New +$16.1K 0.01% 100

Other funds holding JNJ

Bear Mountain Capital's JNJ Position: Q2 2026 in Review

Bear Mountain Capital increased its Johnson & Johnson (JNJ) stake by 0.78% in Q2 2026, buying an estimated $233 and bringing the position to 130 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #70.

Bear Mountain Capital first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $35.1K in Q4 2025. 2,214 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bear Mountain Capital held 130 shares of Johnson & Johnson worth $33K as of Q2 2026.
  • Bear Mountain Capital bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #70 holding.
  • Bear Mountain Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Bear Mountain Capital's Johnson & Johnson position peaked at $35.1K in Q4 2025.
  • 2,214 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.